Literature DB >> 21978020

Reduced effect of Tasmanian devil facial tumor disease at the disease front.

Rodrigo Hamede1, Shelly Lachish, Katherine Belov, Gregory Woods, Alexandre Kreiss, Anne-Maree Pearse, Billie Lazenby, Menna Jones, Hamish McCallum.   

Abstract

Pathogen-driven declines in animal populations are increasingly regarded as a major conservation issue. The Tasmanian devil (Sarcophilus harrisii) is threatened with extinction by devil facial tumor disease, a unique transmissible cancer. The disease is transmitted through direct transfer of tumor cells, which is possible because the genetic diversity of Tasmanian devils is low, particularly in the major histocompatibility complex genes of the immune system. The far northwest of Tasmania now holds the last remaining disease-free wild devil populations. The recent discovery of unique major histocompatibility complex genotypes in the northwestern region of Tasmania has raised the possibility that some animals may be resilient to the disease. We examined the differences in the epidemiology and population effects of devil facial tumor disease at 3 well-studied affected sites in eastern Tasmania and 1 in western Tasmania (West Pencil Pine). In contrast to the 3 eastern sites, there has been no rapid increase in disease prevalence or evidence of population decline at West Pencil Pine. Moreover, this is the only onsite at which the population age structure has remained unaltered 4 years after the first detection of disease. The most plausible explanations for the substantial differences in population effects and epidemiology of the disease between eastern and western sites are geographic differences in genotypes or phenotypes of devils and functional differences between tumor strains in the 2 regions. We suggest that conservation efforts focus on identifying whether either or both these explanations are correct and then, if resistance alleles exist, to attempt to spread the resistant alleles into affected populations. Such assisted selection has rarely been attempted for the management of wildlife diseases, but it may be widely applicable. ©2011 Society for Conservation Biology.

Entities:  

Mesh:

Year:  2011        PMID: 21978020     DOI: 10.1111/j.1523-1739.2011.01747.x

Source DB:  PubMed          Journal:  Conserv Biol        ISSN: 0888-8892            Impact factor:   6.560


  28 in total

1.  Disease swamps molecular signatures of genetic-environmental associations to abiotic factors in Tasmanian devil (Sarcophilus harrisii) populations.

Authors:  Alexandra K Fraik; Mark J Margres; Brendan Epstein; Soraia Barbosa; Menna Jones; Sarah Hendricks; Barbara Schönfeld; Amanda R Stahlke; Anne Veillet; Rodrigo Hamede; Hamish McCallum; Elisa Lopez-Contreras; Samantha J Kallinen; Paul A Hohenlohe; Joanna L Kelley; Andrew Storfer
Journal:  Evolution       Date:  2020-06-03       Impact factor: 3.694

2.  Mitogen-activated Tasmanian devil blood mononuclear cells kill devil facial tumour disease cells.

Authors:  Gabriella K Brown; Cesar Tovar; Anne A Cooray; Alexandre Kreiss; Jocelyn Darby; James M Murphy; Lynn M Corcoran; Silvana S Bettiol; A Bruce Lyons; Gregory M Woods
Journal:  Immunol Cell Biol       Date:  2016-04-19       Impact factor: 5.126

3.  A second transmissible cancer in Tasmanian devils.

Authors:  Ruth J Pye; David Pemberton; Cesar Tovar; Jose M C Tubio; Karen A Dun; Samantha Fox; Jocelyn Darby; Dane Hayes; Graeme W Knowles; Alexandre Kreiss; Hannah V T Siddle; Kate Swift; A Bruce Lyons; Elizabeth P Murchison; Gregory M Woods
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-28       Impact factor: 11.205

4.  Infectious disease and sickness behaviour: tumour progression affects interaction patterns and social network structure in wild Tasmanian devils.

Authors:  David G Hamilton; Menna E Jones; Elissa Z Cameron; Douglas H Kerlin; Hamish McCallum; Andrew Storfer; Paul A Hohenlohe; Rodrigo K Hamede
Journal:  Proc Biol Sci       Date:  2020-12-09       Impact factor: 5.349

5.  Telomere Length is a Susceptibility Marker for Tasmanian Devil Facial Tumor Disease.

Authors:  Lane E Smith; Menna E Jones; Rodrigo Hamede; Rosana Risques; Austin H Patton; Patrick A Carter; Andrew Storfer
Journal:  Ecohealth       Date:  2020-10-30       Impact factor: 3.184

6.  Disease and the dynamics of extinction.

Authors:  Hamish McCallum
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-10-19       Impact factor: 6.237

7.  Transmissible cancer in Tasmanian devils: localized lineage replacement and host population response.

Authors:  Rodrigo K Hamede; Anne-Maree Pearse; Kate Swift; Leon A Barmuta; Elizabeth P Murchison; Menna E Jones
Journal:  Proc Biol Sci       Date:  2015-09-07       Impact factor: 5.349

8.  Density trends and demographic signals uncover the long-term impact of transmissible cancer in Tasmanian devils.

Authors:  Billie T Lazenby; Mathias W Tobler; William E Brown; Clare E Hawkins; Greg J Hocking; Fiona Hume; Stewart Huxtable; Philip Iles; Menna E Jones; Clare Lawrence; Sam Thalmann; Phil Wise; Howel Williams; Samantha Fox; David Pemberton
Journal:  J Appl Ecol       Date:  2018-02-05       Impact factor: 6.528

9.  Two Decades of the Impact of Tasmanian Devil Facial Tumor Disease.

Authors:  Gregory M Woods; Samantha Fox; Andrew S Flies; Cesar D Tovar; Menna Jones; Rodrigo Hamede; David Pemberton; A Bruce Lyons; Silvana S Bettiol
Journal:  Integr Comp Biol       Date:  2018-12-01       Impact factor: 3.326

10.  Evolution of a contagious cancer: epigenetic variation in Devil Facial Tumour Disease.

Authors:  Beata Ujvari; Anne-Maree Pearse; Sarah Peck; Collette Harmsen; Robyn Taylor; Stephen Pyecroft; Thomas Madsen; Anthony T Papenfuss; Katherine Belov
Journal:  Proc Biol Sci       Date:  2012-11-07       Impact factor: 5.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.